US Stem Cell Inc (USRM)

[Zues]

Insightful post D.L. The FDA argument is full of holes. But will the appellate justices see the obvious? Could they be waiting for a ruling in the CA case before posting their opinion?

If "I" were a justice on the appellate court, I would want to see what transpires in the CA case before passing judgement. If it were the other-way-round, we might have seen the CA case rescheduled for a later date...but that hasn't happened.

I expect the courts to be focused mostly on determining disputes surrounding terminologies, classifications, and guidance. Yet these same judges cannot be ignorant to the swing in public opinion towards needing (not wanting) RTT and self determination. Unlike experimental drug therapies, the real question surrounding stem cell treatments focuses more on effectiveness as opposed to bodily harm. When we look at the role of the FDA as protectors of the people, our legal system must respect the need for people to determine what is best for themselves through knowledge gained from patient-provider consultation.